Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-25 @ 3:12 PM
NCT ID:
NCT02760368
Group ID:
EG002
Title:
Arm 3: Placebo q2w + Methotrexate
Description:
Placebo Subcutaneous q2w + Methotrexate (oral)
Placebo administered subcutaneously once every 2 weeks + concomitant background therapy (Methotrexate) at a stable dose of 15 to 25 mg/week (or ≥10 mg/week if there is documented intolerance to higher doses) with a stable route of administration (oral, subcutaneous, or intramuscular)
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
142
Other Number Affected:
35
Other Number At Risk:
142
Study:
NCT02760368
Results Section:
NCT02760368
Adverse Events Module:
NCT02760368